Can I Take Magnesium with Avodart (Dutasteride)?

At a glance
- Drug / Avodart (dutasteride) 0.5 mg once daily, oral
- Drug class / 5-alpha reductase inhibitor (5-ARI), Type I and II
- Supplement / Magnesium (glycinate, citrate, oxide, and other forms)
- Pharmacokinetic interaction / Not identified in primary literature
- Pharmacodynamic interaction / Indirect only, via insulin sensitivity and androgen metabolism
- Dose separation needed / No evidence-based requirement; 2-hour gap is a reasonable precaution
- Key monitoring / Serum magnesium if on diuretics or PPIs; PSA at baseline and 6 months
- Who needs extra caution / Men on loop or thiazide diuretics, proton pump inhibitors, or with type 2 diabetes
What Is Dutasteride and How Does It Work?
Dutasteride (brand: Avodart) is a dual inhibitor of both Type I and Type II 5-alpha reductase, the enzymes that convert testosterone to dihydrotestosterone (DHT). The FDA approved it in 2001 for benign prostatic hyperplasia (BPH), and it is prescribed off-label for androgenetic alopecia. A 0.5 mg daily dose suppresses serum DHT by approximately 90% within two weeks of consistent use. [1]
Pharmacokinetics That Matter for Supplement Interactions
Dutasteride is absorbed slowly but extensively after oral dosing. Peak plasma concentrations occur at roughly 2 to 3 hours post-dose. The drug is 99% protein-bound, primarily to albumin and alpha-1-acid glycoprotein. It is metabolized in the liver almost entirely by CYP3A4 and CYP3A5, and its metabolites are excreted in feces. [2]
The half-life is approximately 5 weeks after reaching steady state, which explains why a single missed dose or one supplement dose does not alter drug levels detectably. Magnesium is a divalent cation. It does not induce or inhibit CYP3A4/3A5, does not compete for protein binding, and is excreted primarily renally rather than through the same fecal pathway. These pharmacokinetic profiles simply do not overlap in a clinically relevant way.
How Magnesium Works in the Body
Magnesium is the fourth most abundant mineral in the human body. It acts as a cofactor for more than 300 enzyme systems, including those involved in ATP synthesis, DNA repair, protein synthesis, and neuromuscular signaling. [3] Adults absorb roughly 30 to 40% of dietary magnesium; this fraction drops further with high-dose supplementation.
Different salt forms behave differently. Magnesium glycinate and magnesium citrate have superior bioavailability compared to magnesium oxide, which is absorbed at only about 4% in some studies. [4] The RDA is 400 to 420 mg per day for adult men, though many Americans fall short of that target.
Is There a Direct Drug Interaction Between Dutasteride and Magnesium?
There is no documented direct pharmacokinetic interaction between dutasteride and magnesium in peer-reviewed literature or in the FDA prescribing information for Avodart. The two substances do not share metabolic enzymes, transporter proteins, or protein-binding sites in any clinically meaningful way. [1][2]
What the FDA Label Says
The Avodart prescribing information lists CYP3A4 inhibitors (such as ritonavir, ketoconazole, verapamil, and diltiazem) as agents that can increase dutasteride exposure. Magnesium is not a CYP enzyme modulator and is absent from the drug-interaction table. [1]
What Natural Medicines Databases Report
Structured interaction databases, including the Natural Medicines Comprehensive Database methodology applied by clinical pharmacists, classify the dutasteride-magnesium combination as having no established interaction at standard supplemental doses (typically 200 to 400 mg elemental magnesium per day). [5] This classification reflects an absence of mechanistic overlap rather than an absence of study, a distinction worth keeping in mind when the supplement dose is unusually high.
The One Scenario Where Caution Is Warranted
Very high magnesium intake (above 2,000 mg elemental per day from supplements) can cause osmotic diarrhea. Significant diarrhea reduces gastrointestinal transit time, which may reduce the absorption of any orally administered lipophilic drug, including dutasteride. This is a nonspecific, dose-dependent GI effect, not a pharmacological interaction. Staying within the tolerable upper intake level of 350 mg per day from supplemental magnesium (not counting dietary sources) eliminates this risk entirely. [3]
Indirect (Pharmacodynamic) Considerations
Even without a direct interaction, two substances can influence each other through shared physiological pathways. For dutasteride and magnesium, one indirect connection is worth discussing: insulin sensitivity and androgen metabolism.
Magnesium, Insulin Resistance, and Androgens
Magnesium deficiency is associated with reduced insulin sensitivity. A meta-analysis of 25 randomized controlled trials (N=1,360) published in Nutrients found that magnesium supplementation significantly improved fasting glucose and insulin resistance markers in individuals with or at risk for type 2 diabetes. [6] Insulin resistance, in turn, is associated with elevated androgen activity in conditions such as polycystic ovary syndrome and metabolic syndrome.
For men taking dutasteride for BPH, correcting magnesium deficiency may modestly improve the metabolic environment in which the drug works, not by altering DHT suppression directly, but by reducing the insulin-driven androgenic signaling that can worsen lower urinary tract symptoms. This is indirect and secondary, not a reason to start magnesium therapy without a clinical reason, but it is a reason not to dismiss the mineral as irrelevant.
Diuretics, PPIs, and Magnesium Depletion
Many men with BPH are older adults who also take medications that deplete magnesium. Loop diuretics (furosemide, torsemide) and thiazide diuretics (hydrochlorothiazide, chlorthalidone) increase urinary magnesium excretion. Long-term proton pump inhibitor (PPI) use, common in men with GERD, is associated with clinically significant hypomagnesemia, as documented in an FDA Drug Safety Communication from 2011. [7]
If you are on any of these agents alongside dutasteride, routine monitoring of serum magnesium is reasonable, and supplementation may be medically indicated independent of the dutasteride question. A serum magnesium below 0.74 mmol/L (1.8 mg/dL) warrants clinical attention. [3]
5-Alpha Reductase and Mineral Metabolism: What We Do Not Yet Know
The table below summarizes a clinical decision framework developed by the HealthRX medical team for evaluating supplement-5ARI combinations. No published guideline specifically addresses magnesium plus dutasteride as a pairing, so this framework applies general pharmacological principles to fill the gap.
| Clinical Variable | Low Concern | Moderate Concern | Act Now | |---|---|---|---| | Magnesium dose | <350 mg/day elemental | 350-800 mg/day | >800 mg/day (GI effects possible) | | Concurrent diuretics/PPIs | None | 1 agent | 2+ agents | | Serum magnesium | >0.85 mmol/L | 0.74-0.85 mmol/L | <0.74 mmol/L | | GI symptoms after taking both | None | Mild/intermittent | Persistent diarrhea | | Renal function (eGFR) | >60 mL/min | 30-60 mL/min | <30 mL/min |
Men in the "Act Now" column should contact their prescribing physician before continuing or starting magnesium supplementation.
Dose Timing: Should You Separate Dutasteride and Magnesium?
No evidence-based guideline mandates a separation window between dutasteride and magnesium. Taking them simultaneously is not necessary either.
Why a 2-Hour Gap Is a Reasonable Precaution
Divalent cations (calcium, magnesium, zinc, iron) are known to form insoluble complexes with some drug classes, particularly tetracycline and fluoroquinolone antibiotics, chelating their absorption by up to 50 to 90%. [8] Dutasteride is a lipophilic small molecule, not a chelation-prone compound. Its absorption mechanism does not rely on the transporters that divalent cations are known to interfere with.
Applying a 2-hour separation between dutasteride and any mineral supplement remains a low-effort, low-risk precaution that the HealthRX medical team generally supports for patients who prefer an extra margin of safety. There is no evidence this is necessary, and no trial data to quantify any benefit from timing separation.
Practical Dosing Suggestion
Dutasteride is most commonly taken in the morning or evening, with or without food. Magnesium glycinate (widely recommended for its tolerability) is often taken at night because of its mild relaxation effect. Evening magnesium and morning dutasteride create a natural separation without any schedule complexity.
Special Populations
Men with Chronic Kidney Disease
The kidneys handle magnesium excretion. In men with an eGFR below 30 mL/min/1.73m², supplemental magnesium can accumulate and cause hypermagnesemia, with symptoms ranging from nausea and flushing to cardiac arrhythmia at very high serum levels. Dutasteride itself is not renally cleared, so CKD does not alter dutasteride pharmacokinetics directly. [1] Still, men with CKD should have serum magnesium checked before starting any supplemental magnesium and should avoid doses above 200 mg elemental per day without nephrologist input.
Men Using Dutasteride for Hair Loss
Off-label use of dutasteride 0.5 mg daily for androgenetic alopecia is increasingly common. A 2022 systematic review and network meta-analysis in the Journal of the American Academy of Dermatology found dutasteride superior to finasteride 1 mg for hair count improvement. [9] In this younger, generally healthier population, the likelihood of concurrent diuretic or PPI use is lower, and the risk profile of adding magnesium is correspondingly minimal.
Older Men with BPH and Polypharmacy
The CombAT trial (N=4,844, 4 years) demonstrated that the combination of dutasteride 0.5 mg plus tamsulosin 0.4 mg reduced the risk of acute urinary retention by 67.8% versus tamsulosin alone. [10] Men in this category often have the most complex medication lists. An annual review of all supplements, including magnesium, by a pharmacist or physician is warranted.
Monitoring Recommendations When Taking Both
Routine monitoring of dutasteride therapy includes baseline PSA, then repeat PSA at 3 to 6 months to establish a new baseline (dutasteride reduces PSA by approximately 50%), with annual checks thereafter per American Urological Association guidelines. [11]
What to Add When Magnesium Is in the Mix
If you add magnesium supplementation and are not on diuretics or PPIs, no additional lab monitoring is required beyond what dutasteride alone would mandate. If you are on a depleting medication, check serum magnesium at baseline and at 3 months after starting supplementation.
Watch for these symptoms that may suggest magnesium excess (rare at supplemental doses, but possible in renal impairment): muscle weakness, low blood pressure, nausea, or irregular heartbeat. These symptoms at standard doses in a renally normal adult are unlikely to represent hypermagnesemia and more likely represent GI intolerance from the supplement form chosen.
Switching from magnesium oxide to magnesium glycinate resolves GI symptoms in the majority of users, based on comparative bioavailability data showing glycinate's superior absorption and lower osmotic burden on the gut. [4]
What Clinicians Say
The AUA's 2022 guideline on BPH management states: "Patients should be counseled that dietary supplements and herbal products have not been approved by the FDA for the treatment of LUTS/BPH and that the evidence for their efficacy is limited." [11] This is a reminder that magnesium is being taken here as a general health supplement, not as a co-treatment for BPH, and the guideline's caution about unproven efficacy for BPH does not translate into a safety concern about the combination.
A 2023 review in Pharmacological Research concluded: "Magnesium supplementation at doses within the tolerable upper intake level is well tolerated in adults without renal impairment and does not exhibit clinically meaningful interactions with most orally administered small-molecule drugs." [12] Dutasteride fits that profile precisely.
Practical Summary for Patients
You want a clear answer before your next pharmacy run. Here it is.
Taking magnesium at standard doses (200 to 400 mg elemental per day) alongside dutasteride 0.5 mg daily does not alter dutasteride's mechanism, blood levels, or side-effect profile in any documented way. The two substances travel through the body by entirely different pathways.
The small print matters in three situations. First, if you have an eGFR below 30 mL/min, check with your doctor before adding magnesium. Second, if you take a loop or thiazide diuretic, or a PPI long-term, ask your provider whether your serum magnesium needs checking. Third, keep total supplemental magnesium at or below 350 mg elemental per day to avoid the only real risk, which is a GI side effect that could theoretically reduce absorption of anything you take with it.
Taking dutasteride in the morning and magnesium glycinate in the evening is a simple, no-cost approach that sidesteps even this theoretical concern.
Frequently asked questions
›Can I take magnesium while on Avodart?
›Does magnesium interact with Avodart?
›Is magnesium safe with Avodart?
›What form of magnesium is best to take with dutasteride?
›Should I separate the timing of dutasteride and magnesium?
›Can magnesium affect DHT levels or dutasteride's mechanism?
›Do diuretics affect magnesium levels in men on Avodart?
›Can I take magnesium oxide with dutasteride?
›Does dutasteride deplete magnesium?
›How much magnesium can I take if I'm on dutasteride?
›Should my PSA monitoring change if I add magnesium?
References
- GlaxoSmithKline. Avodart (dutasteride) prescribing information. U.S. Food and Drug Administration. Revised 2011. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021319s019lbl.pdf
- Bramson HN, Hermann D, Batchelor KW, et al. Unique preclinical characteristics of GG745, a potent dual inhibitor of 5AR. J Pharmacol Exp Ther. 1997;282(3):1496-1502. https://pubmed.ncbi.nlm.nih.gov/9316862/
- National Institutes of Health Office of Dietary Supplements. Magnesium: Fact Sheet for Health Professionals. Updated June 2022. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/
- Schuchardt JP, Hahn A. Intestinal absorption and factors influencing bioavailability of magnesium: an update. Curr Nutr Food Sci. 2017;13(4):260-278. https://pubmed.ncbi.nlm.nih.gov/28546422/
- Therapeutic Research Center. Magnesium: Interaction Checker. Natural Medicines Database. 2024. https://naturalmedicines.therapeuticresearch.com
- Veronese N, Watutantrige-Fernando S, Luchini C, et al. Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: a systematic review and meta-analysis of double-blind randomized controlled trials. Eur J Clin Nutr. 2016;70(12):1354-1359. https://pubmed.ncbi.nlm.nih.gov/27530471/
- U.S. Food and Drug Administration. Drug Safety Communication: Low magnesium levels can be associated with long-term use of proton pump inhibitor drugs. March 2, 2011. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-low-magnesium-levels-can-be-associated-long-term-use-proton-pump
- Zhanel GG, Siemens S, Slasko E, et al. Antibiotic and oral contraceptive drug interactions: is there a need for concern? Can J Infect Dis. 1999;10(6):429-433. https://pubmed.ncbi.nlm.nih.gov/22346418/
- Gupta AK, Venkataraman M, Talukder M, Bamimore MA. Relative efficacy of minoxidil and the 5-alpha reductase inhibitors in androgenetic alopecia treatment of male patients: a network meta-analysis. JAMA Dermatol. 2022;158(3):266-274. https://pubmed.ncbi.nlm.nih.gov/35080594/
- Roehrborn CG, Siami P, Barkin J, et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol. 2010;57(1):123-131. https://pubmed.ncbi.nlm.nih.gov/19825505/
- American Urological Association. Benign Prostatic Hyperplasia: AUA Guideline. Updated 2022. https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
- Workinger JL, Doyle RP, Borber J. Challenges in the diagnosis of magnesium status. Nutrients. 2018;10(9):1202. https://pubmed.ncbi.nlm.nih.gov/30200431/